Skip to content
Wenlo
Sign in
← Markets

Revolution Medicines, Inc.

Revolution Medicines, Inc. (RVMD) — Form 144: Proposed sale of shares

144RVMDFiled Nov 12, 2026, 7:56 AM ET

AI-generated summary

JACK LEE ANDERS, an Officer of Revolution Medicines, Inc., proposed to sell 35,750 shares of Common stock with an aggregate market value of $6,901,895 through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares were acquired through the exercise of stock options on November 11, 2026. The proposed sale is associated with a trading plan adopted on August 12, 2026.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Seller
JACK LEE ANDERS
Relationship
Officer
Shares to sell
35,750
Market value
$6,901,895.00
Approximate sale date
Nov 11, 2026
Broker
Morgan Stanley Smith Barney LLC Executive Financial Services
Acquired
Nov 11, 2026 · Exercise of Stock Options

Rule 10b5-1 plan · adopted Aug 12, 2026

Remarks
  1. Sales that were executed on November 11, 2026 are being reported on this Form 144 filed on November 12, 2026 given the EDGAR system was not accepting filings on November 11, 2026 in observance of the federal holiday.

More RVMD filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.